Inventor
SIRCAR ILA
US56 patents
⚠️ This page may combine multiple inventors who share the name “SIRCAR ILA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
WARNER LAMBERT CO
39 patentsUS5036053AJul 30, 1991
Diol-containing renin inhibitors
WARNER LAMBERT CO130 citations97
US5322950AJun 21, 1994
Imidazole with angiotensin II antagonist properties
WARNER LAMBERT CO77 citations96
US5124347AJun 23, 1992
3-5-ditertiarybutylphenyl-4-hydroxymethylidene derivatives of 1,3-dihydro-2H-indole-2-ones as antiinflammatory agents
WARNER LAMBERT CO64 citations96
US5071837ADec 10, 1991
Novel renin inhibiting peptides
WARNER LAMBERT CO109 citations96
US5063207ANov 5, 1991
Renin inhibitors, method for using them, and compositions containing them
WARNER LAMBERT CO107 citations96
US5034512AJul 23, 1991
Branched backbone renin inhibitors
WARNER LAMBERT CO105 citations96
US4404203ASep 13, 1983
Substituted 6-phenyl-3(2H)-pyridazinones useful as cardiotonic agents
WARNER LAMBERT CO61 citations96
US4397854AAug 9, 1983
Substituted 6-phenyl-3(2H)-pyridazinones useful as cardiotonic agents
WARNER LAMBERT CO106 citations96
US4353905AOct 12, 1982
Substituted 4,5-dihydro-6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones and 6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones
WARNER LAMBERT CO51 citations96
US5389661AFeb 14, 1995
Imidazole and 1,2,4-triazole derivatives with angiotensin II antagonist properties
WARNER LAMBERT CO32 citations93
US4734415AMar 29, 1988
Substituted 4,5-dihydro-6-(substituted)-phenyl-3(2H)-pyridazinones and 6-(substituted) phenyl-3(2H)-pyridazinones
WARNER LAMBERT CO35 citations92
US5153226AOct 6, 1992
Acat inhibitors for treating hypocholesterolemia
WARNER LAMBERT CO32 citations91
US5242939ASep 7, 1993
Anilide derivatives with angiotensin ii antagonist properties
WARNER LAMBERT CO18 citations74
US5045540ASep 3, 1991
Amino acid derivatives with angiotensin II antagonist properties
WARNER LAMBERT CO17 citations74
US4820842AApr 11, 1989
2-substituted-1,4-dihydropyridines
WARNER LAMBERT CO14 citations74
US4723014AFeb 2, 1988
Process for the preparation of 2-substituted-1,4-dihydropyridines
WARNER LAMBERT CO9 citations74
US4602019AJul 22, 1986
Indeno[1,2-c]pyridazin-3-one derivatives useful as cardiotonic and antihypertensive agents
WARNER LAMBERT CO10 citations74
US4599332AJul 8, 1986
4,5-dihydro-6-[2-[4-(1H-imidazol-1-yl)phenyl]-ethenyl]-3(2H)-pyridazinones and related compounds
WARNER LAMBERT CO9 citations74
US4521416AJun 4, 1985
4,5-Dihydro-6-[(substituted)-1H-imidazol-4-yl or 5-yl]-3(2H)-pyridazinones and 6-[(substituted)-1H-imidazol-4-yl or 5-yl]-3(2H)-pyridazinones
WARNER LAMBERT CO12 citations74
US4503061AMar 5, 1985
Substituted phenyl-pyridinones as cardiotonic agents
WARNER LAMBERT CO9 citations74
US4397855AAug 9, 1983
4-(Substituted)-α, α-dimethyl-1-piperazine pentanoic acids and derivatives as anti-arteriosclerotic agents and method
WARNER LAMBERT CO18 citations74
US4351950ASep 28, 1982
Anti-arteriosclerotic agents
WARNER LAMBERT CO11 citations74
US5260278ANov 9, 1993
Diol-containing renin inhibitors
WARNER LAMBERT CO6 citations73
US5024994AJun 18, 1991
Renin inhibitors IV
WARNER LAMBERT CO11 citations73
US4413011ANov 1, 1983
Substituted 2,2-dimethyl-5-phenoxypentanoic acid benzamides as anti-arteriosclerotic agents and method
WARNER LAMBERT CO9 citations73
US4980351ADec 25, 1990
3-aminopropoxyaryl derivatives having cardiotonic and antihypertensive use and compositions thereof
WARNER LAMBERT CO7 citations66
US5041552AAug 20, 1991
Amino acid derivatives with angiotensin II antagonist properties
WARNER LAMBERT CO3 citations63
US4840955AJun 20, 1989
6-substituted-2(1H)-quinolinones and related compounds having use as cardiotonic, antihypertensive, and antithrombotic agents
WARNER LAMBERT CO3 citations63
US4717730AJan 5, 1988
4,5-dihydro-6-(substituted)phenyl-5-methyl-3-(2H)-pyridazinones and pharmaceutical compositions containing the compounds as active components
WARNER LAMBERT CO4 citations63
US4701453AOct 20, 1987
Substituted indeno-pyridazinones
WARNER LAMBERT CO2 citations63
US4656170AApr 7, 1987
N-[4-[2-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)ethenyl]phenyl]acetamide and related compounds
WARNER LAMBERT CO4 citations63
US5238923AAug 24, 1993
Amino-substituted heterocycles as renin inhibitors
WARNER LAMBERT CO4 citations62
US4554282ANov 19, 1985
Substituted 2,2-dimethyl-5-phenoxypentanoic acid benzamides as anti-arteriosclerotic agents and method
WARNER LAMBERT CO4 citations62
US4508718AApr 2, 1985
Cardiotonic and antihypertensive oxadiazinone compounds
WARNER LAMBERT CO4 citations60
US5288851AFeb 22, 1994
Renin inhibitors, processes for preparing them, methods for using them, and compositions containing them
WARNER LAMBERT CO0 citations52
US5162527ANov 10, 1992
Renin inhibitors, processes for preparing them, methods for using them, and compositions containing them
WARNER LAMBERT CO1 citations52
US4607037AAug 19, 1986
Cardiotonic 2(1H)-pyridinones
WARNER LAMBERT CO1 citations52
US4397852AAug 9, 1983
[3,6-Pyridazinediylbis(thio)]bis-[2,2-dimethylalkanoic acids] and derivatives as anti-arteriosclerotic agents and method
WARNER LAMBERT CO0 citations52
US5453488ASep 26, 1995
Amino-substituted heterocycles as renin inhibitors
WARNER LAMBERT CO0 citations51
TANABE SEIYAKU CO
4 patentsUS6855843B2Feb 15, 2005
Inhibitors of α4 mediated cell adhesion
TANABE SEIYAKU CO22 citations92
US6521666B1Feb 18, 2003
Inhibitors of α4 mediated cell adhesion
TANABE SEIYAKU CO34 citations92
US7026501B2Apr 11, 2006
Inhibitors of α4 mediated cell adhesion
TANABE SEIYAKU CO26 citations91
US6897225B1May 24, 2005
Inhibitors of αLβ2 mediated cell adhesion
TANABE SEIYAKU CO21 citations91
MITSUBISHI TANABE PHARMA CORP
4 patentsUS7342012B2Mar 11, 2008
Inhibitors of αLβ2 mediated cell adhesion
MITSUBISHI TANABE PHARMA CORP0 citations51
US7872151B2Jan 18, 2011
Inhibitors of α4 mediated cell adhesion
MITSUBISHI TANABE PHARMA CORP0 citations50
US7671090B2Mar 2, 2010
Inhibitors of α4 mediated cell adhesion
MITSUBISHI TANABE PHARMA CORP0 citations50
US7456217B2Nov 25, 2008
Inhibitors of alpha4 mediated cell adhesion
MITSUBISHI TANABE PHARMA CORP0 citations50
(unassigned)
3 patentsShowing the top 50 of 56 patents by PatentIndex Score.